ArticleBasic and clinical andrology2025
Sexual dysfunction and quality of life in males with genital warts.
Article in Basic and clinical andrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epidemiology of Human Papillomavirus in the Middle East and North Africa: A Review of Genotypic Prevalence, Vaccination Challenges, and Non-Cervical Clinical Outcomes.Diseases (Basel, Switzerland) · 2026Review
- Genital Warts and Male Sexual Dysfunction: An IIEF-15-Based Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGenital warts caused by human papillomavirus, significantly impact male sexual function and quality of life. However, the extent of dysfunction varies across studies, necessitating further investigation. This study aims to assess sexual dysfunction and quality of life in men with GWs.
resultsA cross-sectional study was conducted among men diagnosed with GWs. Sexual function was evaluated using the International Index of Erectile Function while the Dermatology Life Quality Index measured quality-of-life impairment. Data were analyzed to determine the severity and distribution of dysfunction across domains. Erectile dysfunction was prevalent, with a mean International Index of Erectile Function score of 14.3 ± 4.2, indicating moderate dysfunction. Orgasmic satisfaction (5.8 ± 2.1) and overall satisfaction (6.5 ± 2.4) were also moderately affected. Quality of life was significantly impaired, with 36.7% experiencing moderate impact, 26.7% reporting a very large impact, and 8% suffering an extreme impact.
conclusionGenital warts contribute to substantial sexual dysfunction and diminished quality of life. The results highlight the need for routine sexual health assessments and psychological support. Integrating medical and psychosocial care may improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.